[Antipyretic effects of lysinsalicylate VUFB (author's transl)].
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D005260:Female; D005334:Fever / Q000188:drug therapy*; D008239:Lysine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D051381:Rats; D012459:Salicylates / Q000627:therapeutic use*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D012459:Salicylates; C025771:lysinsalicylate; D008239:Lysine
Antipyretická aktivita lysinsalicylanu VUFB.